A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization

Alexandra R Brown, Byron J Gajewski, Lauren S Aaronson, Dinesh Pal Mudaranthakam, Suzanne L Hunt, Scott M Berry, Melanie Quintana, Mamatha Pasnoor, Mazen M Dimachkie, Omar Jawdat, Laura Herbelin, Richard J Barohn, Alexandra R Brown, Byron J Gajewski, Lauren S Aaronson, Dinesh Pal Mudaranthakam, Suzanne L Hunt, Scott M Berry, Melanie Quintana, Mamatha Pasnoor, Mazen M Dimachkie, Omar Jawdat, Laura Herbelin, Richard J Barohn

Abstract

Background: In the last few decades, the number of trials using Bayesian methods has grown rapidly. Publications prior to 1990 included only three clinical trials that used Bayesian methods, but that number quickly jumped to 19 in the 1990s and to 99 from 2000 to 2012. While this literature provides many examples of Bayesian Adaptive Designs (BAD), none of the papers that are available walks the reader through the detailed process of conducting a BAD. This paper fills that gap by describing the BAD process used for one comparative effectiveness trial (Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations) that can be generalized for use by others. A BAD was chosen with efficiency in mind. Response-adaptive randomization allows the potential for substantially smaller sample sizes, and can provide faster conclusions about which treatment or treatments are most effective. An Internet-based electronic data capture tool, which features a randomization module, facilitated data capture across study sites and an in-house computation software program was developed to implement the response-adaptive randomization.

Results: A process for adapting randomization with minimal interruption to study sites was developed. A new randomization table can be generated quickly and can be seamlessly integrated in the data capture tool with minimal interruption to study sites.

Conclusion: This manuscript is the first to detail the technical process used to evaluate a multisite comparative effectiveness trial using adaptive randomization. An important opportunity for the application of Bayesian trials is in comparative effectiveness trials. The specific case study presented in this paper can be used as a model for conducting future clinical trials using a combination of statistical software and a web-based application.

Trial registration: ClinicalTrials.gov Identifier: NCT02260388 , registered on 6 October 2014.

Keywords: Adaptive randomization; Bayesian adaptive design; Bayesian randomization; Clinical trial conduct; Data capture; REDCap; Response-adaptive randomization.

Figures

Fig. 1
Fig. 1
An example of first, second, and third interim analysis
Fig. 2
Fig. 2
Overall schematic of the trial’s conduction
Fig. 3
Fig. 3
Screen shots from the randomization procedure within REDCap

References

    1. Bonangelino P, Irony T, Liang S, Li X, Mukhi V, Ruan S, Xu Y, Yang X, Wang C. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting. J Biopharm Stat. 2011;21(5):938–53. doi: 10.1080/10543406.2011.589650.
    1. Berry DA. A guide to drug discovery: Bayesian clinical trials. Nat Rev Drug Discov. 2006;5(1):27–36. doi: 10.1038/nrd1927.
    1. Berry SM, Carlin BP, Lee JJ, Muller P. Bayesian adaptive methods for clinical trials. New York: CRC Press; 2011.
    1. Lee JJ, Chu CT. Bayesian clinical trials in action. Stat Med. 2012;31:2955–72. doi: 10.1002/sim.5404.
    1. Patient Centered Outcomes Research Institute (PCORI) (2012). PCORI methodology standards. . Accessed 13 Aug 2014.
    1. Esserman LJ, Berry DA, Demichele A, et al. Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657. J Clin Oncol. 2012;30(26):3242–9. doi: 10.1200/JCO.2011.39.2779.
    1. Zhou X, Liu S, Kim ES, Herbst RS, Lee JJ. Bayesian adaptive design for targeted therapy development in lung cancer—a step toward personalized medicine. Clinical Trials. 2008;5:181–93. doi: 10.1177/1740774508091815.
    1. Connor JT, Luce BR, Broglio KR, Ishak KJ, Mullins CD, Vanness DJ, Fleurence R, Saunders E, Davis BR. Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study. Clinical Trials. 2013;10(5):805–27. doi: 10.1177/1740774513497293.
    1. Pasnoor M, Dimachkie MM, Barohn RJ. Cryptogenic sensory polyneuropathy. Neurol Clin. 2013;31:463–76. doi: 10.1016/j.ncl.2013.01.008.
    1. Pasnoor M, Nascimento OJ, Trivedi J, Wolfe GI, Nations S, Herbelin L, De Freitas MG, Quintanilha G, Khan S, Dimachkie M, Barohn R. North America and South America (NA-SA) neuropathy project. Int J Neurosci. 2013;123(8):563–7. doi: 10.3109/00207454.2013.782026.
    1. Burckhardt CS, Jones KD. Adult measures of pain: The McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), Short-Form McGill Pain Questionnaire (SF-MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven-Yale Multidisciplinary Pain Inventory (WHYMPI) Arthritis Care Res. 2003;49(S5):S96–S104. doi: 10.1002/art.11440.
    1. Gajewski BJ, Berry SM, Quintana M, Pasnoor M, Dimachkie M, Herbelin L, Barohn R. Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot. Stat Med. 2015;34(7):1134–49. doi: 10.1002/sim.6403.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. doi: 10.1016/j.jbi.2008.08.010.
    1. SAS software. Copyright, SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA.
    1. R Core Team . R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2012.
    1. Collins SP, Lindsell CJ, Pang PS, Storrow AB, Peacock WF, Levy P, Rahbar MH, Del Junco D, Gheorghiade M, Berry DA. Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial. Am Heart J. 2012;164(2):138–45. doi: 10.1016/j.ahj.2011.11.023.
    1. McIIwain J. Data standards harmonization: a look at the past, present, and future of interoperability across the clinical research spectrum: Advanstar Communications; 1 May 2010. Available from: . Accessed June 2015.
    1. Meurer WJ, Lewis RJ, Berry DA. Adaptive clinical trials: a partial remedy for the therapeutic misconception? JAMA. 2012;307(22):2377–8. doi: 10.1001/jama.2012.4174.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner